HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amra Adrovic Selected Research

Amra Adrovic Research Topics

Disease

8Juvenile Arthritis (Juvenile Idiopathic Arthritis)
05/2022 - 04/2017
6Rheumatic Diseases (Rheumatism)
05/2022 - 01/2020
5COVID-19
05/2022 - 01/2020
4Familial Mediterranean Fever (Periodic Disease)
05/2022 - 04/2018
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 10/2020
3Hypertension (High Blood Pressure)
01/2022 - 01/2020
3Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 01/2019
3Neoplasms (Cancer)
01/2022 - 08/2020
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 01/2017
2Fever (Fevers)
01/2022 - 01/2020
2Uveitis
08/2021 - 09/2020
2Latent Tuberculosis
10/2020 - 12/2018
2Pain (Aches)
10/2020 - 09/2020
1Mental Disorders (Mental Disorder)
10/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Disease Progression
01/2022
1Dyspnea (Shortness of Breath)
01/2022
1Arthritis (Polyarthritis)
08/2021
1Hypersensitivity (Allergy)
05/2021
1Myositis (Idiopathic Inflammatory Myopathies)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Dermatomyositis (Dermatopolymyositis)
01/2021
1Human Influenza (Influenza)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
11/2020
1Connective Tissue Diseases (Connective Tissue Disease)
10/2020
1Tuberculosis (Tuberculoses)
10/2020
1malar rash
09/2020
1Sacroiliitis
09/2020
1Hematologic Neoplasms (Hematological Malignancy)
08/2020
1Poisoning
08/2020
1Myalgia
01/2020
1Neurologic Manifestations (Neurological Manifestations)
01/2020
1Polyarteritis Nodosa (Periarteritis Nodosa)
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Tonsillitis
01/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Cytopenia
01/2020
1Schmid-Fraccaro syndrome
01/2020
1Virus Diseases (Viral Diseases)
01/2020
1Severe Acute Respiratory Syndrome
01/2020
1Abdominal Pain (Pain, Abdominal)
01/2020
1Communicable Diseases (Infectious Diseases)
04/2019
1Infections
04/2019
1Spondylarthropathies
03/2019
1Vasculitis (Vasculitides)
03/2019
1Celiac Disease (Celiac Sprue)
04/2018
1Localized Scleroderma (Morphea)
01/2018
1Amyloidosis
01/2018
1Pulmonary Hypertension
01/2018
1Necrosis
04/2017

Drug/Important Bio-Agent (IBA)

8Biological ProductsIBA
05/2022 - 12/2018
4Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022 - 01/2020
3Antirheumatic Agents (DMARD)IBA
05/2022 - 01/2020
3AntibodiesIBA
04/2021 - 11/2020
3tocilizumab (atlizumab)FDA Link
01/2021 - 04/2017
3Etanercept (Enbrel)FDA Link
08/2020 - 04/2017
3ColchicineFDA LinkGeneric
01/2020 - 01/2018
2Immunoglobulin G (IgG)IBA
05/2022 - 01/2020
2Immunoglobulins (Immunoglobulin)IBA
05/2022 - 05/2021
2Carbon MonoxideIBA
01/2022 - 01/2021
2AutoantibodiesIBA
01/2021 - 09/2020
2Tuberculin (PPD)IBA
10/2020 - 12/2018
2HLA-B27 Antigen (HLA B27 Antigen)IBA
09/2020 - 01/2016
2Infliximab (Remicade)FDA Link
04/2019 - 04/2017
1CytokinesIBA
10/2022
1Immunoglobulin A (IgA)IBA
05/2022
1COVID-19 VaccinesIBA
03/2022
1sinovac COVID-19 vaccineIBA
03/2022
1VaccinesIBA
03/2022
1mRNA VaccinesIBA
03/2022
1BNT162 VaccineIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1SteroidsIBA
01/2022
1Pharmaceutical PreparationsIBA
08/2021
1Rheumatoid FactorIBA
08/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021
1Thyroxine (Levothyroxine)FDA LinkGeneric
04/2021
1ThyroglobulinFDA Link
04/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
04/2021
1Iodide Peroxidase (Deiodinase)IBA
04/2021
1InterleukinsIBA
01/2021
1Prostaglandins AIBA
01/2021
1Oseltamivir (Tamiflu)FDA Link
01/2021
1Biomarkers (Surrogate Marker)IBA
10/2020
1Tumor Necrosis Factor InhibitorsIBA
10/2020
1MetalsIBA
08/2020
1MercuryIBA
08/2020
1DiamondIBA
01/2020
1GlucocorticoidsIBA
01/2020
1Adenosine DeaminaseIBA
01/2020
1Sodium Glutamate (Accent)IBA
03/2019
1Oxygen (Dioxygen)IBA
01/2019
1Bosentan (Tracleer)FDA Link
01/2018
1Adalimumab (Humira)FDA Link
04/2017
1Interleukin-6 (Interleukin 6)IBA
04/2017
1Abatacept (Orencia)FDA Link
04/2017
1canakinumabFDA Link
04/2017

Therapy/Procedure

5Therapeutics
01/2022 - 04/2017
1Biological Therapy
01/2022
1Critical Care (Surgical Intensive Care)
01/2020